Lexicon Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.74
| LXRX Stock | USD 0.76 0.07 8.43% |
Lexicon |
Lexicon Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lexicon Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lexicon Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lexicon Pharmaceuticals generated a negative expected return over the last 90 days | |
| Lexicon Pharmaceuticals has high historical volatility and very poor performance | |
| Lexicon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Lexicon Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.2 M. Net Loss for the year was (177.12 M) with loss before overhead, payroll, taxes, and interest of (52.68 M). | |
| Lexicon Pharmaceuticals currently holds about 61.97 M in cash with (161.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Over 82.0% of the company shares are owned by institutional investors |
Lexicon Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lexicon Stock often depends not only on the future outlook of the current and potential Lexicon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lexicon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 221.1 M | |
| Cash And Short Term Investments | 170 M |
Lexicon Pharmaceuticals Technical Analysis
Lexicon Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Lexicon Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lexicon Pharmaceuticals. In general, you should focus on analyzing Lexicon Stock price patterns and their correlations with different microeconomic environments and drivers.
Lexicon Pharmaceuticals Predictive Forecast Models
Lexicon Pharmaceuticals' time-series forecasting models is one of many Lexicon Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lexicon Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lexicon Pharmaceuticals
Checking the ongoing alerts about Lexicon Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lexicon Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lexicon Pharmaceuticals generated a negative expected return over the last 90 days | |
| Lexicon Pharmaceuticals has high historical volatility and very poor performance | |
| Lexicon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Lexicon Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.2 M. Net Loss for the year was (177.12 M) with loss before overhead, payroll, taxes, and interest of (52.68 M). | |
| Lexicon Pharmaceuticals currently holds about 61.97 M in cash with (161.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Over 82.0% of the company shares are owned by institutional investors |
Additional Tools for Lexicon Stock Analysis
When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.